Literature DB >> 8181497

Use of recombinant human granulocyte-macrophage colony stimulating factor in an infant with reticular dysgenesis.

C Azcona1, V Alzina, P Barona, L Sierrasesúmaga, I Villa-Elízaga.   

Abstract

We present the case of a 2-month-old infant with reticular dysgenesis who was treated with recombinant granulocyte-macrophage colony stimulating factor with the aim of stimulating granulopoiesis while awaiting bone marrow transplant.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8181497     DOI： 10.1007/bf01958976

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  6 in total

Review 1.  Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1).

Authors:  G J Lieschke; A W Burgess
Journal:  N Engl J Med       Date:  1992-07-02       Impact factor: 91.245

2.  Use of recombinant human granulocyte colony stimulating factor in reticular dysgenesis.

Authors:  W Bujan; A Ferster; N Azzi; C Devalck; A Leriche; E Sariban
Journal:  Br J Haematol       Date:  1992-05       Impact factor: 6.998

3.  Stimulation of myelopoiesis in a patient with congenital neutropenia: biology and nature of response to recombinant human granulocyte-macrophage colony-stimulating factor.

Authors:  S Vadhan-Raj; S S Jeha; S Buescher; A LeMaistre; G Yee; L Lu; J Lloreta; W K Hoots; W N Hittelman; J U Gutterman
Journal:  Blood       Date:  1990-02-15       Impact factor: 22.113

4.  Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia.

Authors:  K Welte; C Zeidler; A Reiter; W Müller; E Odenwald; L Souza; H Riehm
Journal:  Blood       Date:  1990-03-01       Impact factor: 22.113

5.  Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis.

Authors:  M A Bonilla; A P Gillio; M Ruggeiro; N A Kernan; J A Brochstein; M Abboud; L Fumagalli; M Vincent; J L Gabrilove; Karl Welte; Lawrence M Souza; Richard J O'Reilly
Journal:  N Engl J Med       Date:  1989-06-15       Impact factor: 91.245

6.  European experience of bone-marrow transplantation for severe combined immunodeficiency.

Authors:  A Fischer; P Landais; W Friedrich; G Morgan; B Gerritsen; A Fasth; F Porta; C Griscelli; S F Goldman; R Levinsky
Journal:  Lancet       Date:  1990-10-06       Impact factor: 79.321
  6 in total
  3 in total

1.  Severe combined immunodeficiency (SCID) associated neutropenia: a lesson from monozygotic twins.

Authors:  T Niehues; K Schwarz; M Schneider; H Schroten; E Schröder; V Stephan; V Wahn
Journal:  Arch Dis Child       Date:  1996-04       Impact factor: 3.791

Review 2.  The inherited bone marrow failure syndromes.

Authors:  S Deborah Chirnomas; Gary M Kupfer
Journal:  Pediatr Clin North Am       Date:  2013-12       Impact factor: 3.278

Review 3.  Neutropenia in primary immunodeficiency.

Authors:  Robert Sokolic
Journal:  Curr Opin Hematol       Date:  2013-01       Impact factor: 3.284
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.